| Issue Date | Title | Author(s) |
| 2021-02-18 | Cocrystals of Apixaban with Improved Solubility and Permeability: Formulation, Physicochemical Characterization, Pharmacokinetic Evaluation, and Computational Studies. | Madan, JR; Waghmare, SV; Patil, RB; Awasthi, R; Dua, K |
| 2021-06-14 | Efavirenz Loaded Mixed Polymeric Micelles: Formulation, Optimization, and <i>In Vitro</i> Characterization. | Madan, JR; Dere, SG; Awasthi, R; Dua, K |
| 2021-02-16 | Formulation and evaluation of nano structured lipid carriers for intranasal delivery of buspirone hydrochloride | Mathure, D; Madan, JR; Ranpise, HA; Awasthi, R; Dua, K; Gujar, KN |
| 2020-07 | Formulation and In Vitro Evaluation of Casein Nanoparticles as Carrier for Celecoxib. | Madan, JR; Ansari, IN; Dua, K; Awasthi, R |
| 2020-01-01 | Formulation, optimization, and evaluation of ketoconazole loaded nanostructured lipid carrier gel for topical delivery | Ranpise, HA; Gujar, KN; Pawar, SC; Awasthi, R; Dua, K; Mathure, D; Madan, JR |
| 2020-05 | Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. | Madan, JR; Khobaragade, S; Dua, K; Awasthi, R |
| 2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
| 2018-12 | Novel drug delivery approaches in treating pulmonary fibrosis. | Dua, K; Awasthi, R; Madan, JR; Chellappan, DK; Nalluri, BN; Gupta, G; Bebawy, M; Hansbro, PM |
| 2019-03-01 | Therapeutic strategies for targeting non-coding RNAs with special emphasis on novel delivery systems | Awasthi, R; Madan, JR; Malipeddi, H; Dua, K; Kulkarni, GT |
